ClinicalTrials.gg
Drug

Valganciclovir clinical trials

Also written Valcyte.

A product of Ganciclovir; its studies count on that page too.

studies test it
76
open now
6
in phase 3
26
first study started
1997

How each study uses Valganciclovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Valganciclovir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Mar 2001 · VALCYTE · NDA 021304 (FDA, Drugs@FDA)
European Union
18 Mar 1997 · Vitrasert Implant · EMEA/H/C/000120 (EMA; as Ganciclovir; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Valganciclovir
54
valganciclovir [Valcyte]
5
Valganciclovir (Valcyte)
3
Valganciclovir Hydrochloride
3
Valganciclovirhydrochloride
2

Brand

Valcyte
21

Development codes

Ro 107-9070
1

Studies by the year they started

74 studies that test it; most in 2004 (8)

Studies that test Valganciclovir, by start year
YearStudies
19971
20001
20012
20023
20034
20048
20053
20067
20071
20084
20091
20102
20115
20124
20131
20141
20154
20161
20171
20184
20193
20202
20213
20243
20252
20263

Who runs them

Industry 21 · Other 55

Hoffmann-La Roche (11) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · University of California, San Francisco (4) · Viracta Therapeutics, Inc. (3) · National Cancer Institute (NCI) (2) · Dr. Ann C.T.M. Vossen (2) · Dr. Reddy's Laboratories Limited (2) · University of Washington (2)

Often tested with

Tested in the same studies.

Nanatinostat (3) · Zidovudine (2) · Bortezomib (2) · Mycophenolic Acid (2) · Valacyclovir (2) · Acyclovir (2) · Brincidofovir (2) · Everolimus (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Valganciclovir is the comparator. A study of two new drugs counts under both.

  • 1Letermovir · Columbia University · next primary completion Jan 2028
Reaching primary completion within a year · 4

Studies that test Valganciclovir.

Studies

Open first, then newest update. How each study uses Valganciclovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 76

See all 76 studies that test Valganciclovir →

Given beside what is tested · 9 — Valganciclovir is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with Valganciclovir

Codes

What other systems call Valganciclovir · ClinicalTrials.gg INT006757

  • MeSH (NLM) D000077562ValganciclovirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) GCU97FKN3RVALGANCICLOVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 275891Confirmed FDA, Wikidata
  • Wikidata Q423384valganciclovirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2629ValganciclovirConfirmed FDA, Wikidata
  • DrugBank DB01610One source Wikidata

Also registered as valganciclovir hydrochloride (UNII 4P3T9QF9NZ · RxNorm 283815).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.